Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Labcorp Genetics (formerly Invitae) LabCorp United States | 24 | 8 |
|
F5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Factor V deficiency, 227400, Autosomal recessive (Congenital factor V deficiency) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 409 | 164 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 208 | 81 |
|
Molecular Diagnostics Children's Hospital of Wisconsin United States | 2 | 1 |
|
Hemophilia: Factor II and Factor V gene mutation study Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 2 | 2 |
|
Factor V Deficiency via the F5 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Invitae Hereditary Thrombophilia Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 24 | 11 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 79 |
|
Molecular Haemostasis & Thrombosis Synnovis Analytics LLP - Guy's and St. Thomas' NHS Foundation Trust United Kingdom | 1 | 1 |
|
Coagulation Factor Deficiency Panel PreventionGenetics, part of Exact Sciences United States | 21 | 20 |
|
Baylor Genetics United States | 11 | 3 |
|
Factor V Leiden Mutation Panel Baylor Genetics United States | 5 | 1 |
|
Clotting factor deficiency panel. 16-gene NGS panel. Genologica Medica Spain | 29 | 16 |
|
Bleeding disorder / coagulopathy panel. NGS panel of 62 genes. Genologica Medica Spain | 96 | 62 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
Factor V Cambridge mutation analysis Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
Factor V leiden mutation analysis Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.